Certara, Inc. (CERT) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance
March 4, 2021 4:10 PM ESTYear-over-year 2020 revenue grew 17% to $243.5 million
Raised $768.5 million in gross IPO proceeds for the Company and selling stockholders
PRINCETON, N.J.--(BUSINESS WIRE)-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its preliminary results for the fourth quarter and full year ended December 31, 2020.
Highlights:
Revenue was $64.6 million in the fourth quarter of 2020, and $243.5 million for the full year, representing year-over-year growth of 20% and 17%. Reported net loss was ($54.4) million in the fourth quarter of 2020, and ($49.4)... More


